General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Faraday Pharmaceuticals(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Xenter(NONE)
CONSULTING FEES/HONORARIA: Faraday Pharmaceuticals(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Xenter(NONE)
© 2024 American College of Cardiology Foundation. All rights reserved.